Our Services
Medical Information
Helpful Resources
Published on: 10/14/2026
Follistatin 344 is marketed as a myostatin-blocking peptide said to build muscle, reduce fat, and aid recovery, but these claims rest almost entirely on animal gene-therapy studies and have not been proven safe or effective in humans. It is not FDA-approved for any use, is sold only as a research chemical, and unregulated products carry risks of contamination, dosing errors, unknown effects on tissue growth, and banned-substance violations in sport. Several important distinctions separate the lab evidence from the marketing, and they are detailed below before considering any use.
If you are weighing a peptide like this because of fatigue, muscle loss, slow recovery, or unexplained body composition changes, those symptoms often have treatable medical causes worth identifying first. Take a free, instant, online symptom check to see what may be driving how you feel and get clear guidance on your next steps.
Last reviewed for medical accuracy: 10/13/2026
What Is Follistatin 344?
Follistatin 344 is a naturally occurring protein precursor made up of 344 amino acids. It belongs to the follistatin family, which binds and neutralizes activins—molecules that regulate muscle growth, inflammation, and hormone release. In the body, the signal peptide is removed, producing shorter, active forms (commonly Follistatin 288 and Follistatin 315). Researchers often refer to the full-length precursor as “follistatin 344” when discussing gene therapy or laboratory studies.
How Follistatin 344 Works
Common Claims Around Follistatin 344
Enthusiasts and supplement marketers often assert that follistatin 344 can:
What Science Has Actually Proven
While the theoretical benefits are attractive, solid human data are very limited. Here’s what credible research shows so far:
Animal Studies
Early-Phase Human Trials
Key Takeaways from Research
Safety and Unanswered Questions
Regulatory Status
Should You Consider Follistatin 344?
Given the current evidence:
If you’re experiencing unexplained muscle weakness, hormonal issues, or other concerning symptoms, you might consider a free, online symptom check, using the doctor approved Ubie Symptom Checker.
Next Steps and Professional Guidance
This summary is based on the best available research as of now. Science may evolve, and new trials could clarify follistatin 344’s role in human health. Before pursuing any unapproved therapy:
Bottom Line
Follistatin 344 shows promise for increasing muscle mass in animals and is under early investigation for rare muscle diseases in humans. However, its use for general fitness or anti-aging is not supported by solid clinical evidence, and safety remains unproven. Always consult a qualified healthcare provider before considering experimental treatments—especially those that could carry serious or life-threatening risks.
(References)
* Patel K. Follistatin. Int J Biochem Cell Biol. 1998 Oct;30(10):1087-93. doi: 10.1016/s1357-2725(98)00064-8. PMID: 9785474.
* Kubo K, Ikebukuro T, Yata H. Effects of squat training with different depths on lower limb muscle volumes. Eur J Appl Physiol. 2019 Sep;119(9):1933-1942. doi: 10.1007/s00421-019-04181-y. Epub 2019 Jun 22. PMID: 31230110.
* Seo MW, Jung SW, Kim SW, Lee JM, Jung HC, Song JK. Effects of 16 Weeks of Resistance Training on Muscle Quality and Muscle Growth Factors in Older Adult Women with Sarcopenia: A Randomized Controlled Trial. Int J Environ Res Public Health. 2021 Jun 23;18(13). doi: 10.3390/ijerph18136762. Epub 2021 Jun 23. PMID: 34201810; PMCID: PMC8267934.
* Guignabert C, Savale L, Boucly A, Thuillet R, Tu L, Ottaviani M, Rhodes CJ, De Groote P, Prévot G, Bergot E, Bourdin A, Howard LS, Fadel E, Beurnier A, Roche A, Jevnikar M, Jaïs X, Montani D, Wilkins MR, Sitbon O, Humbert M. Serum and Pulmonary Expression Profiles of the Activin Signaling System in Pulmonary Arterial Hypertension. Circulation. 2023 Jun 13;147(24):1809-1822. doi: 10.1161/CIRCULATIONAHA.122.061501. Epub 2023 Apr 25. PMID: 37096577.
* Zhang Y, Dos Santos M, Huang H, Chen K, Iyengar P, Infante R, Polanco PM, Brekken RA, Cai C, Caijgas A, Cano Hernandez K, Xu L, Bassel-Duby R, Liu N, Olson EN. A molecular pathway for cancer cachexia-induced muscle atrophy revealed at single-nucleus resolution. Cell Rep. 2024 Aug 27;43(8):114587. doi: 10.1016/j.celrep.2024.114587. Epub 2024 Aug 7. PMID: 39116208; PMCID: PMC11472345.
* Brown DW, Wee P, Bhandari P, Bukhari A, Grin L, Vega H, Hejazi M, Sosnowski D, Ablack J, Clancy EK, Pink D, Kumar J, Solis Ares MP, Lamb S, Quevedo R, Rawal B, Elian F, Rana N, Morales L, Govindasamy N, Todd B, Delmage A, Gupta S, McMullen N, MacKenzie D, Beatty PH, Garcia H, Parmar M, Gyoba J, McAllister C, Scholz M, Duncan R, Raturi A, Lewis JD. Safe and effective in vivo delivery of DNA and RNA using proteolipid vehicles. Cell. 2024 Sep 19;187(19):5357-5375.e24. doi: 10.1016/j.cell.2024.07.023. Epub 2024 Sep 10. PMID: 39260374.
* Zhang M, Song Y, Zhu J, Ding P, Chen N. Effectiveness of low-load resistance training with blood flow restriction vs. conventional high-intensity resistance training in older people diagnosed with sarcopenia: a randomized controlled trial. Sci Rep. 2024 Nov 18;14(1):28427. doi: 10.1038/s41598-024-79506-9. Epub 2024 Nov 18. PMID: 39558011; PMCID: PMC11574083.
* Xiong Z, Zheng W, Wang H, Gao Y, Wang C. Effects of functional strength training on pain, function, and lower extremity biomechanics in patients with patellofemoral pain syndrome: a randomized clinical trial. J Orthop Surg Res. 2025 Jan 16;20(1):50. doi: 10.1186/s13018-025-05482-z. Epub 2025 Jan 16. PMID: 39825450; PMCID: PMC11740520.
* Zhuang M, Gu Y, Wang Z, He X, Chen N. Effects of 12-week whole-body vibration training versus resistance training in older people with sarcopenia. Sci Rep. 2025 Feb 27;15(1):6981. doi: 10.1038/s41598-025-91644-2. Epub 2025 Feb 27. PMID: 40011687; PMCID: PMC11865505.
* Bhasin S, Wang C, Chandra MS, Gagliano-Jucá T, Jasuja R. Mechanisms of Testosterone's Anabolic Effects on Muscle and Function: Controversies and New Insights. Endocr Rev. 2026 Mar 11;47(2):280-300. doi: 10.1210/endrev/bnaf041. PMID: 41355050; PMCID: PMC13017102.
We would love to help them too.
For First Time Users
We provide a database of explanations from real doctors on a range of medical topics. Get started by exploring our library of questions and topics you want to learn more about.
Was this page helpful?
Purpose and positioning of servicesUbie Doctor's Note is a service for informational purposes. The provision of information by physicians, medical professionals, etc. is not a medical treatment. If medical treatment is required, please consult your doctor or medical institution. We strive to provide reliable and accurate information, but we do not guarantee the completeness of the content. If you find any errors in the information, please contact us.